fda compounded semaglutide enforcement news 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Hims is in the crosshairs.
Description
Not every patient needs the highest dose
That combination can work against your progress, even if the occasional drink feels manageable
Wegovy, Oral Wegovy, Zepbound, and Foundayoall FDA-approvedare excellent alternatives for your weight management needs
Retatrutide has shown higher weight loss results in clinical trials, with an average of up to 24% body weight reduction, compared to around 15% with semaglutide
They're effective, no doubt
These steps reduce the chance of weight regain when retatrutide is discontinued
